Growth stocks are money machines that generate substantial—and sustainable—positive cash flow, and whose revenues and earnings are expected to increase at faster rates than the average company.
Growth companies typically have some sort of competitive advantage that allows them to fend off competitors and keep the lion’s share of business to themselves. They also have many different investment opportunities (or a few large opportunities) that promise to generate high returns.
Uncover a variety of top picks in growth stocks and the hottest growth trends, past and present, in our growth investing article archive below. Also, be sure to check out our exclusive free guide on the top growth stocks to own now, featuring three top growth stocks that we believe will be worth much more in the future than they cost today.
Animal healthcare is becoming an increasingly lucrative business, and many of the major drugmakers already operate in this arena. In fact, Pfizer recently spun off its animal healthcare division, which is now a standalone company with a $16 billion market cap.
Here’s an unvarnished look at the prospects of this iconic but struggling technology company.
Here’s why the bear case against the buck is overstated.
Although the drugmaker’s treatment for hepatitis C has shown great promise during clinical trials, investors still have time to take advantage of this stock before shares head higher in anticipation of the drug’s approval.
Despite increasing market euphoria, it’s still wise to carefully hunt for undervalued bargains.
Look for plenty of growth ahead for this small software developer.
These small biotech companies may be high-risk plays, but they boast several key characteristics that should help them navigate the regulatory process and then prevail in the marketplace.
The US recovery is lifting stocks, but investors are prudent to remain wary.
Look for a frequent profit plan from this fast-growing airline.
The biotech space is rife with unproven startups, but this established name is suitable for most investors and currently trades at a compelling value.